Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07534709) titled 'Suzetrigine for Opioid-Free Recovery After Cesarean Delivery' on April 7.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Care Provider).
Primary Sponsor: University of Texas at Austin
Condition:
Cesarean Delivery
Cesarean Section
Pain, Postoperative
Opioid Consumption, Postoperative
Intervention:
Drug: Suzetrigine
Recruitment Status: Not recruiting
Phase: Phase 4
Date of First Enrollment: June 2026
Target Sample Size: 90
Countries of Recruitment:
United States
To know more, visit https...